These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia. Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552 [TBL] [Abstract][Full Text] [Related]
27. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor]. Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385 [TBL] [Abstract][Full Text] [Related]
28. Amiodarone-induced 2 to 1 atrioventricular block in association with prolongation of the QT interval. McMahon CJ; Laird WP; Fenrich AL Cardiol Young; 2003 Jun; 13(3):305-7. PubMed ID: 12903882 [TBL] [Abstract][Full Text] [Related]
29. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination]. Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426 [TBL] [Abstract][Full Text] [Related]
30. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation. Kosior D; Opolski G; Torbicki A Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496 [TBL] [Abstract][Full Text] [Related]
31. A toxic combination. Zeineh NS Am J Med; 2010 Aug; 123(8):707-8. PubMed ID: 20670723 [No Abstract] [Full Text] [Related]
32. [Amiodarone, a new anti-arrhythmia agent in arrhythmia associated with myocardial infarct]. Watanabe Y; Katoh T Nihon Rinsho; 1983 Dec; 41(12):2766-70. PubMed ID: 6674562 [No Abstract] [Full Text] [Related]
34. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy. McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429 [TBL] [Abstract][Full Text] [Related]
35. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings. Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675 [TBL] [Abstract][Full Text] [Related]
36. The use of amiodarone in children. Coumel P; Lucet V; Do Ngoc D Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):930-9. PubMed ID: 6195613 [TBL] [Abstract][Full Text] [Related]
37. The role of intravenous amiodarone in the management of cardiac arrhythmias. Desai AD; Chun S; Sung RJ Ann Intern Med; 1997 Aug; 127(4):294-303. PubMed ID: 9265430 [TBL] [Abstract][Full Text] [Related]
38. Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone. Nademanee K; Hendrickson JA; Cannom DS; Goldreyer BN; Singh BN Am Heart J; 1981 Jun; 101(6):759-68. PubMed ID: 7234654 [No Abstract] [Full Text] [Related]
39. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. McKenna WJ; Harris L; Perez G; Krikler DM; Oakley C; Goodwin JF Br Heart J; 1981 Aug; 46(2):173-8. PubMed ID: 7196769 [No Abstract] [Full Text] [Related]
40. [ECG observations on terminating tachyarrhythmia by intravenous amiodarone]. Xu ML Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):14-6. PubMed ID: 4006697 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]